Buprenorphine Hydrochloride Tablets Market

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.

Buprenorphine Hydrochloride Tablets Market contains market size and forecasts of Buprenorphine Hydrochloride Tablets in global, including the following market information:

Global Buprenorphine Hydrochloride Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Buprenorphine Hydrochloride Tablets Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Buprenorphine Hydrochloride Tablets companies in 2021 (%)

The global Buprenorphine Hydrochloride Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.5mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Buprenorphine Hydrochloride Tablets include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Buprenorphine Hydrochloride Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Buprenorphine Hydrochloride Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, by Type, 2021 (%)

0.5mg

2mg

Global Buprenorphine Hydrochloride Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, by Application, 2021 (%)

Analgesic

Opioid Antagonist

Global Buprenorphine Hydrochloride Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Buprenorphine Hydrochloride Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Buprenorphine Hydrochloride Tablets revenues share in global market, 2021 (%)

Key companies Buprenorphine Hydrochloride Tablets sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Buprenorphine Hydrochloride Tablets sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Siegfried

Sanofi

Johnson Matthey

Mallinckrodt

Noramco

Unichemlabs

Arevipharma

Resonance-labs

Sun Pharma

Rusan Pharma

Micro Orgo Chem

Faranshimi

Teva